Cargando…

Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma

BACKGROUND: Increased level of serum S100B can serve as a marker of metastatic spread in patients with cutaneous melanoma (CM). In patients with elevated S100 B and/or clinical signs of disease progression PET-CT scan is a valuable tool for discovering metastases and planning treatment. The aims of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peric, Barbara, Zagar, Ivana, Novakovic, Srdjan, Zgajnar, Janez, Hocevar, Marko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162584/ https://www.ncbi.nlm.nih.gov/pubmed/21810220 http://dx.doi.org/10.1186/1471-2407-11-328

Ejemplares similares

Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families
por: Peric, Barbara, et al.
Publicado: (2008)

Completely Resected Stage III Melanoma Controversy - 15 Years of National Tertiary Centre Experience
por: Peric, Barbara, et al.
Publicado: (2020)

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
por: Stegel, Vida, et al.
Publicado: (2011)

Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families
por: NOVAKOVIĆ, SRDJAN, et al.
Publicado: (2012)

Lower tumour burden and better overall survival in melanoma patients with regional lymph node metastases and negative preoperative ultrasound
por: Pilko, Gasper, et al.
Publicado: (2011)

Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families
por: Krajc, Mateja, et al.
Publicado: (2008)

A patient with a painless neck tumour revealed as a carotid paraganglioma: a case report
por: Peric, Barbara, et al.
Publicado: (2014)

Does Regular Quality Control Improve the Quality of Surgery in Slovenian Breast Cancer Screening Program?
por: Perhavec, Andraz, et al.
Publicado: (2020)

Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence
por: Oblak, Tjaša, et al.
Publicado: (2023)

S‐100B as an extra selection tool for FDG PET/CT scanning in follow‐up of AJCC stage III melanoma patients
por: Deckers, Eric A., et al.
Publicado: (2019)

Thyroid lesions incidentally detected by (18)F-FDG PET-CT — a two centre retrospective study
por: Jamsek, Jan, et al.
Publicado: (2015)

Genetic Counselling, BRCA1/2 Status and Clinico-pathologic Characteristics of Patients with Ovarian Cancer before 50 Years of Age
por: Cvelbar, Mirjam, et al.
Publicado: (2017)

Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients
por: Kudura, Ken, et al.
Publicado: (2021)

Inguinal or inguino-iliac/obturator lymph node dissection after positive inguinal sentinel lymph node in patients with cutaneous melanoma
por: Glumac, Nebojsa, et al.
Publicado: (2012)

Does Concurrent Gynaecological Surgery Affect Infectious Complications Rate after Mastectomy with Implant-based Reconstruction?
por: Pislar, Nina, et al.
Publicado: (2022)

Effectiveness of a Simply Designed Tumor Vaccine in Prevention of Malignant Melanoma Development
por: Novakovic, Srdjan, et al.
Publicado: (1999)

Ruptured epidermal cyst mimicking cutaneous melanoma on F-18 FDG PET/CT
por: Nguyen, Ba D., et al.
Publicado: (2015)

Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma
por: Gornjec, Andreja, et al.
Publicado: (2019)

Granulomatosis after autologous stem cell transplantation in nonHodgkin lymphoma – experience of single institution and a review of literature
por: Boltezar, Lucka, et al.
Publicado: (2016)

Sinonasal malignant melanoma with diffuse carcinomatosis: initial PET/CT staging and follow-up CT/MR imaging
por: Nguyen, Ba D.
Publicado: (2015)

Reduction of overtreatment without reduction of overdiagnosis in patients with differentiated thyroid cancer: mission impossible
por: Oblak, Tjasa, et al.
Publicado: (2021)

Screening Strategy Modification Based on Personalized Breast Cancer Risk Stratification and its Implementation in the National Guidelines – Pilot Study
por: Krajc, Mateja, et al.
Publicado: (2020)

Cutaneous and Vascular Deposits of 18F-NaF by PET/CT in the Follow-Up of Patients with Pseudoxanthoma Elasticum
por: Lillo, Eugenia, et al.
Publicado: (2021)

Health Behaviour Changes of Cutaneous Melanoma Survivors in Slovenia – A Qualitative Study
por: Butina, Mirjam Rogl, et al.
Publicado: (2019)

Optimal scan time for evaluation of parathyroid adenoma with [(18)F]-fluorocholine PET/CT
por: Rep, Sebastijan, et al.
Publicado: (2015)

Prevalence of BRAF, NRAS and c-KIT Mutations in Slovenian Patients with Advanced Melanoma
por: Moltara, Maja Ebert, et al.
Publicado: (2018)

Real-World Data on Detection of Germline and Somatic Pathogenic/Likely Pathogenic Variants in BRCA1/2 and Other Susceptibility Genes in Ovarian Cancer Patients Using Next Generation Sequencing
por: Stegel, Vida, et al.
Publicado: (2022)

PET/CT variants and pitfalls in malignant melanoma
por: Aide, Nicolas, et al.
Publicado: (2022)

Preoperative Screening CT and PET/CT Scanning for Acral Melanoma: Is it Necessary?
por: Ide, Taketoshi, et al.
Publicado: (2021)

S100 as Serum Tumor Marker in Advanced Uveal Melanoma
por: Salzmann, Martin, et al.
Publicado: (2023)

Askin Tumor: CT and FDG-PET/CT Imaging Findings and Follow-Up
por: Xia, Tingting, et al.
Publicado: (2014)

Usefulness of (18)F-FDG PET/CT in Cutaneous Melanoma Patients with Negative Sentinel Lymph Nodes and High Clark Levels
por: Vural Topuz, Özge, et al.
Publicado: (2018)

Non-Cutaneous Melanoma, Findings and Prognostic Value of FDG PET/CT: A Case Series of 23 patients and review of the literature
por: Saidi, Bahare, et al.
Publicado: (2022)

Current status of PET/CT in the diagnosis and follow up of lymphomas
por: Buchpiguel, Carlos Alberto
Publicado: (2011)

New Trends in Cutaneous Melanoma Surgery
por: Scala, Jacopo, et al.
Publicado: (2019)

Elevated serum levels of S100 and survival in metastatic malignant melanoma
Publicado: (1998)

Elevated serum levels of S100 and survival in metastatic malignant melanoma
Publicado: (1998)

Elevated serum levels of S100 and survival in metastatic malignant melanoma.
por: Buer, J., et al.
Publicado: (1997)

A Synopsis of Serum Biomarkers in Cutaneous Melanoma Patients
por: Vereecken, Pierre, et al.
Publicado: (2012)

Serum level of vitamin D3 in cutaneous melanoma
por: de Oliveira, Renato Santos, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nc8stdu7c4lp7pk4fqlch54fb4